Over the projected period, the anatomic pathology market is expected to develop due to increased demand from anatomic pathology service providers as well as research institutes (anatomic pathology research).
The anatomic pathology market has grown as a result of new product introductions and increased mergers and acquisitions. For example, in June 2018, PHC Holdings Corporation finalised the acquisition of Thermo Fisher Scientific Inc.'s Anatomical Pathology division. The acquired Anatomical Pathology business will operate as a separate stand-alone company called Epredia and will be a prominent global provider of comprehensive anatomical pathology solutions.
The global Anatomic Pathology Market is estimated to develop at an 8.2% CAGR between 2022 and 2030.
Top Companies in the Anatomic Pathology Industry
1. Thermo Fisher Scientific: Established in 1956. Thermo Fisher Scientific is an American company that sells laboratory supplies, life science reagents, diagnostics equipment, and tools for use in science. As of mid-2022, the company operates through four segments: analytical technologies (15% of sales); speciality diagnostic products (10% of revenues); life science solutions (30% of revenues); and lab goods and services, which includes CRO services (51% of revenues).
2. F. Hoffman-La Roche AG: Tasmar's rights to production, marketing, and distribution in the United States and a few other non-European Union areas. Parkinson's illness is managed with the medication tasmar. Roche plans to purchase the TIB Molbiol Group, with a closing anticipated for the fourth quarter of 2021
3. Agilent Technologies: Established in 1999. Headquarters are in the United States. Agilent, which was split off from Hewlett-Packard in 1999, has grown into a premier life sciences and diagnostics company. Agilent's measuring technologies now serve a diverse range of clients through its three operating segments: life science and applied tools, cross lab (consisting of life science and applied tools consumables and services), and diagnostics and genomics. Agilent Purchases Artificial Intelligence Technology to Increase Lab Productivity.
4. Danaher Corporation: Danaher's founders changed a real estate firm into an industrial-focused manufacturing firm in 1984. Danaher today primarily manufactures scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions, as a result of a sequence of mergers, acquisitions, and divestitures. The company announced plans to exit its environmental and applied solutions groups in 2023, leaving it only focused on life sciences and diagnostics in late 2022.
5. Quest Diagnostics, Inc.: Established in 1967. In the United States, Quest Diagnostics is a preeminent independent provider of diagnostic testing, data, and services. Over 2,300 patient care centres across the country, as well as numerous doctors' offices and hospitals, collect specimens for the company's clinical testing, anatomic pathology, esoteric testing, and substance addiction testing departments. These departments account for over 95% of the company's revenue.
6. Biocartis NV: Established in 2007. Headquarters are located in Mechelen, Belgium. Biocartis Group NV is a molecular diagnostics firm in the commercial stage. It offers diagnostic solutions to patients, clinicians, payers, and the industry in order to improve clinical practise. The company has created the MDx Idylla molecular diagnostic system for oncology and infectious disease applications. Its products include the EGFR mutation assay, the BRAF mutation test, the NRAS mutation test, and the respiratory panel. The majority of the company's revenue comes from product sales. Biocartis Group NV, an innovative molecular diagnostics firm, today announced its operational highlights and financial results for 2021, presented in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union, as well as selected post-period events and its prognosis for 2022.
7. Sakura FineTechnical Co., Ltd.: Established in 2016. The headquarters are in South Korea. Creator of a stock trading programme that offers stock recommendations and social trading. The company specialises in providing a platform that allows users to trade stocks from various marketplaces, as well as a leaderboard where trades may be ranked based on profit and loss, allowing individuals to trade easily while remaining competitive with other investors. Binance, the world's largest blockchain ecosystem and cryptocurrency infrastructure provider, has announced the acquisition of 100% of Sakura Exchange BitCoin, a Japanese-registered cryptocurrency exchange service provider.
*Definition: Anatomical pathology is the study of organs and tissues to determine the causes and effects of particular diseases.
